about
Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer.Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo.FGFRL1 Promotes Ovarian Cancer Progression by Crosstalk with Hedgehog Signaling.PD-L1 Expression Predicts a Distinct Prognosis in Krukenberg Tumor with Corresponding Origins.Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapyOlaparib induced senescence under P16 or P53 dependent manner in ovarian cancerPyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activationRosiglitazone ameliorates senescence and promotes apoptosis in ovarian cancer induced by olaparibDecreased expression of cell polarity protein Scribble correlated with altered subcellular localization of the Crumbs homologue 3 protein in human adenomyotic endometrial cellsNext-Generation Sequencing Panel Analysis of Clinically Relevant Mutations in Circulating Cell-Free DNA from Patients with Gestational Trophoblastic Neoplasia: A Pilot Study
P50
Q49816432-66BEA283-66D5-44FF-859B-F5430356C9FFQ52354783-9AA9BA06-B166-4A78-B4DC-DD6252076A35Q52575758-37F021D7-C2D8-45B4-80FD-885EDE71D269Q55090803-341ED574-E72F-456A-B68D-B64F9F7D391FQ88394520-0000DA50-2FEF-480C-815B-FDD383F5E489Q91445793-45B3564C-2702-4085-A243-460B26EED3DEQ91531714-0D9A75AB-8A3B-47C3-9603-85945B683B8FQ92455069-9B472781-FAA8-4BAA-A483-459490088B08Q92621298-045BE52C-49DB-49E5-97A0-6180CF00B2A8Q93055148-1267C850-F9B2-4823-AA96-EB73CF73C7B8
P50
description
researcher
@en
wetenschapper
@nl
name
Cong-Jian Xu
@en
Cong-Jian Xu
@nl
type
label
Cong-Jian Xu
@en
Cong-Jian Xu
@nl
prefLabel
Cong-Jian Xu
@en
Cong-Jian Xu
@nl
P31
P496
0000-0002-7954-5892